Formoterol vs salbutamol bid in stable asthmatics
Midgren, B.; Melander, B.; Persson, G.
Chest 98(2 Suppl): 26S
1990
ISSN/ISBN: 0012-3692 Accession: 031491215
Full Text Article emailed within 1 workday: $29.90
Related References
Rosenborg, J.; Bengtsson, T.; Larsson, P.; Blomgren, A.; Persson, G.; Lötvall, J. 2000: Relative systemic dose potency and tolerability of inhaled formoterol and salbutamol in healthy subjects and asthmatics European Journal of Clinical Pharmacology 56(5): 363-370Andrade Capuchinho-Júnior, G.; Marques Dias, R.; Regina da Silva de Carvalho, Sônia. 2008: One hour effects of salbutamol and formoterol on blood pressure, heart rate and oxygen saturation in asthmatics Revista Portuguesa de Pneumologia 14(3): 353-361
Rosenborg, J.; Bengtsson, T.; Larsson, P.; Blomgren, A.; Persson, G.; Lotvall, J. 2002: Relative systemic dose potency and tolerability of inhaled formoterol and salbutamol in healthy subjects and asthmatics European Journal of Clinical Pharmacology 58(4): S53-S60
Profita, M.; Gagliardo, R.; Di Giorgi, R.; Pompeo, F.; Gjomarkaj, M.; Nicolini, G.; Bousquet, J.; Vignola, A.M. 2005: Biochemical interaction between effects of beclomethasone dipropionate and salbutamol or formoterol in sputum cells from mild to moderate asthmatics Allergy 60(3): 323-329
Rico-Méndez, F.G.; Ochoa, G.; Rocío Chapela, M.; Díaz, M.; Cohen, V.; Ibarra, J.; Téllez, E. 1999: Dry powdered formoterol, twice a day versus aerosolized salbutamol, four times a day, in patients with stable asthma Revista Alergia Mexico 46(5): 130-135
Rebuck A.S.; Kesten S.; Chapman K.R.; Gontovnik L.; Hyland R.H.; Knight A.; Malo J.; Mazza J.A.; Moote D.W.; Et Al 1990: A three month double blind comparison of formoterol versus salbutamol in stable asthma Chest 98(2 Suppl): 26S
Steffensen, I.E.; Faurschou, P. 1996: Formoterol as inhalation powder in the treatment of patients with reversible obstructive lung diseases. a 3-month placebo-controlled comparison of the effects of formoterol and salbutamol, followed by a 12-month period with formoterol alone Ugeskrift for Laeger 158(49): 7092-7096
Steffensen, I.; Faurschou, P.; Riska, H.; Rostrup, J.; Wegener, T. 1995: Inhaled formoterol dry powder in the treatment of patients with reversible obstructive airway disease. A 3-month, placebo-controlled comparison of the efficacy and safety of formoterol and salbutamol, followed by a 12-month trial with formoterol Allergy 50(8): 657-663
Ciappi, G.; Mormile, F.; Magnini, P.; Toscano, L.; Bisbano, A.; Valente, S.; Fano, M.; Bernareggi, V. 1991: The bronchodilatory and cardiovascular effect of inhaled naminterol etanterol and salbutamol in stable asthmatics Current Therapeutic Research 50(5): 667-677
Meslier, N.; Racineux, J.L.; Six, P.; Lockhart, A.; Tuchais, E.; Oury, M. 1985: Dose response curves to salbutamol in stable asthmatics role of basal obstruction to airflow American Review of Respiratory Disease 131(4 Suppl): A278
Lotvall, J.; Persson, G.; Larsson, P.; Mardell, C.; Rosenborg, J. 1997: Tolerability of inhaled high doses of formoterol and salbutamol in asthmatic patients maintained on twice daily formoterol 12 mug European Respiratory Journal Suppl 10(25): 103S
Bateman, E.D.; Fairall, L.; Lombardi, D.M.; English, R. 2006: Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol Respiratory Research 7: 13
Aalbers, R.é; Boorsma, M.; van der Woude, H.J.; Jonkers, R.é E. 2010: Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study Respiratory Research 11: 66
Safirstein, B.H.; Dhakhwa, R.B.; Gelb, B.; Fontunato, F.D. 1979: Bronchodilator effects of oral salbutamol and theophylline-salbutamol combinations in chronic steroid-dependent asthmatics Journal of the Medical Society of new Jersey 76(13): 892-894
Ruffin, R.E.; Latimer, K.M.; Crockett, A.J.; Blight, M. 1988: Comparative bronchodilator study of salbutamol and salbutamol sulfate in asthmatics Australian and New Zealand Journal of Medicine 18(3 Suppl 2): 539